| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.7M | -56.7% |
| SG&A Expense | $7.0M | -34.1% |
| Operating Income | -$11.7M | +45.5% |
| Pre-tax Income | -$11.6M | +32.4% |
| Net Income | -$11.6M | +32.4% |
| EPS (Basic) | -$2.31 | -477.5% |
| EPS (Diluted) | -$2.31 | -477.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $187K | -85.6% |
| Current Assets | $385K | -79.7% |
| Total Assets | $1.8M | -56.5% |
| Current Liabilities | $9.0M | +15.1% |
| Total Liabilities | $9.6M | +5.8% |
| Stockholders' Equity | -$7.8M | -59.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.1M | +55.6% |
| Investing Cash Flow | $12K | -99.5% |
| Financing Cash Flow | $8.0M | -58.0% |